Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Myozenin 1 (MYOZ1) (N-Term) Peptide

MYOZ1 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN8106025
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Myozenin 1 (MYOZ1) (N-Term) Peptide (ABIN8106025)

Antigène

Myozenin 1 (MYOZ1)

Origine

Humain

Source

  • 9
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Fonction

    MYOZ1 Peptide - N-terminal region

    Séquence

    IYENHPDVFS DSSMDHFQKF LPTVGGQLGT AGQGFSYSKS NGRGGSQAGG
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti-MYOZ1 Antibody(ARP48397_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    Myozenin 1 (MYOZ1)

    Sujet

    Background Information: Myozenins may serve as intracellular binding proteins involved in linking Z-disk proteins such as alpha-actinin, gamma-filamin, TCAP/telethonin, LDB3/ZASP and localizing calcineurin signaling to the sarcomere. MYOZ1 plays an important role in the modulation of calcineurin signaling. MYOZ1 may play a role in myofibrillogenesis.

    Alternative Symbols: CS-2, FATZ, MYOZ

    Poids moléculaire

    32kDa

    ID gène

    58529

    NCBI Accession

    NP_067068

    UniProt

    Q9NP98
Vous êtes ici:
Chat with us!